Application no. and date | 05725933.5 (espacenet) (Federated) (European Patent Register), 20050318 | Patent/reg. no. and date | DK/EP 1730175, 20100428 | Publication date | 20061213 | Priority no. and date | US 555926 P, 20040324 | EP pub. no. and date |
EP 1730175 20061213 | Effective date | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue Rahway, New Jersey 07065, US | Applicant ref. no. | 09245-9 | Inventor | BRYAN, Janine, T., c/o Merck Sharp & Dohme Corp. 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, BROWNLOW, Michelle, K., c/o Merck Sharp & Dohme Corp. 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, SCHULTZ, Loren, D., c/o Merck Sharp & Dohme Corp. 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, JANSEN, Kathrin, U., c/o Merck Sharp & Dohme Corp. 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | C07K 14/025 (2006.01) | Title | Geoptimaliseerde expressie van HPV 52 L1 in gist | Int. application no. | US2005009199 | Int. publication no. | WO2005097821 | Related patent (certificate) | CA 2015 00067 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|